Ryerson Holding Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Ryerson Holding Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.57B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $4.60B | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $5.11B | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $6.32B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $5.68B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $3.47B | Feb 22, 2023 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.57B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $4.60B | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $5.11B | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $6.32B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $5.68B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $3.47B | Feb 22, 2023 |
| FY2019 | Dec 31, 2019 | $961.50M | Mar 4, 2020 |
| FY2019 | Sep 30, 2019 | $1.10B | Mar 4, 2020 |
| FY2019 | Jun 30, 2019 | $1.20B | Mar 4, 2020 |
| FY2019 | Mar 31, 2019 | $1.23B | Mar 4, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $810.60M | Mar 5, 2018 |
| FY2017 | Sep 30, 2017 | $864.20M | Mar 5, 2018 |
| FY2017 | Jun 30, 2017 | $875.40M | Mar 5, 2018 |
| FY2017 | Mar 31, 2017 | $814.50M | Mar 5, 2018 |
| FY2017 | Dec 31, 2016 | $682.20M | Mar 5, 2018 |
| FY2017 | Sep 30, 2016 | $735.10M | Mar 5, 2018 |
| FY2017 | Jun 30, 2016 | $739.80M | Mar 5, 2018 |
| FY2017 | Mar 31, 2016 | $702.60M | Mar 5, 2018 |
| FY2016 | Dec 31, 2015 | $668.80M | Mar 13, 2017 |
| FY2016 | Sep 30, 2015 | $790.00M | Mar 13, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $782.20M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $834.20M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $1.02B | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $1.31B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.15B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $621.10M | Feb 22, 2023 |
| FY2019 | Dec 31, 2019 | $180.40M | Mar 4, 2020 |
| FY2019 | Sep 30, 2019 | $204.40M | Mar 4, 2020 |
| FY2019 | Jun 30, 2019 | $211.80M | Mar 4, 2020 |
| FY2019 | Mar 31, 2019 | $231.30M | Mar 4, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($56.40M) | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | ($8.60M) | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $145.70M | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $391.00M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $294.30M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | ($65.80M) | Feb 22, 2023 |
| FY2019 | Dec 31, 2019 | $26.40M | Mar 4, 2020 |
| FY2019 | Sep 30, 2019 | $10.10M | Mar 4, 2020 |
| FY2019 | Jun 30, 2019 | $16.40M | Mar 4, 2020 |
| FY2019 | Mar 31, 2019 | $29.50M | Mar 4, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($30.80M) | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $31.50M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $228.10M | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $578.70M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $545.20M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $64.60M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $210.80M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $139.20M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $101.10M | Mar 4, 2020 |
| FY2018 | Dec 31, 2016 | $122.10M | Mar 5, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $809.60M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $801.20M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $793.50M | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $735.20M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $711.20M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $554.30M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $636.80M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $614.70M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $481.40M | Mar 4, 2020 |
| FY2018 | Dec 31, 2016 | $447.50M | Mar 5, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $87.00M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $204.90M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $365.10M | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $501.20M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $35.00M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $277.90M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $193.10M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $57.40M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | ($2.50M) | Mar 4, 2020 |
| FY2018 | Dec 31, 2016 | $24.80M | Mar 5, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.50M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $99.60M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $121.90M | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $105.10M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $59.30M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $26.00M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $45.80M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $38.40M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $25.10M | Mar 4, 2020 |
| FY2018 | Dec 31, 2016 | $23.00M | Mar 5, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.40B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $2.44B | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $2.57B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $2.33B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $2.37B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $1.80B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $2.02B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $2.09B | Mar 4, 2020 |
| FY2018 | Dec 31, 2017 | $1.71B | Mar 5, 2019 |
| FY2017 | Dec 31, 2016 | $1.56B | Mar 5, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.64B | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $1.62B | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $1.66B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $1.44B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $1.82B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $1.66B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $1.84B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $2.01B | Mar 4, 2020 |
| FY2018 | Dec 31, 2017 | $1.72B | Mar 5, 2019 |
| FY2017 | Dec 31, 2016 | $1.61B | Mar 5, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $753.10M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $815.30M | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $905.90M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $885.10M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $537.20M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $138.80M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $172.60M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $73.20M | Mar 4, 2020 |
| FY2018 | Dec 31, 2017 | ($10.00M) | Mar 5, 2019 |
| FY2017 | Dec 31, 2016 | ($50.80M) | Mar 5, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $161.50M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $161.80M | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $157.80M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $129.20M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $124.10M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $120.30M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $120.30M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $120.30M | Mar 4, 2020 |
| FY2018 | Dec 31, 2017 | $115.30M | Mar 5, 2019 |
| FY2017 | Dec 31, 2016 | $103.20M | Mar 5, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $698.80M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $779.60M | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $813.20M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $692.50M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $321.70M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $33.80M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $99.60M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $14.20M | Mar 4, 2020 |
| FY2018 | Dec 31, 2017 | ($95.10M) | Mar 5, 2019 |
| FY2017 | Dec 31, 2016 | ($112.20M) | Mar 5, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.90M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $27.70M | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $54.30M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $39.20M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $51.20M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $61.40M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $11.00M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $23.20M | Mar 4, 2020 |
| FY2018 | Dec 31, 2017 | $77.40M | Mar 5, 2019 |
| FY2017 | Dec 31, 2016 | $80.70M | Mar 5, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | 10 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 7 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Feb 22, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 4, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 4, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 4, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 4, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | 10 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 7 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Feb 22, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 4, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 4, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 4, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 4, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.10M | Feb 23, 2026 |
| FY2025 | Dec 31, 2024 | $24.80M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $24.80M | Feb 23, 2026 |
| FY2024 | Dec 31, 2022 | $19.90M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $6.40M | Feb 21, 2024 |